Long-Acting Injectables For Schizophrenia

This video discusses the advantages and considerations of long-acting injectables (LAIs) compared with oral antipsychotics for the treatment of schizophrenia. The beneficial effects of LAIs on adherence and relapse rates are presented along with some potential obstacles that patients may experience.

lan “Tony” Amberg, MSN, APRN, PMHNP-BC
This module was medically reviewed by Alan “Tony” Amberg, MSN, APRN, PMHNP-BC, Northwestern Memorial Hospital.





Read the Transcript here.